We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cardlytics
CDLX
$21M
| $15.9M | 0.07% |
12,563
+4,395
| +54% | +$4.96M |
|
302
Factset
FDS
$9.05B
| $15.8M | 0.07% |
47,174
+25,708
| +120% | +$8.42M |
|
303
Ball Corp
BALL
$17B
| $15.6M | 0.07% |
192,993
-19,695
| -9% | -$1.71M |
|
|
PPD
304
DELISTED
PPD, Inc. Common Stock
PPD
| $15.6M | 0.07% |
338,478
+121,878
| +56% | +$5.51M |
|
305
Akebia Therapeutics
AKBA
$327M
| $15.6M | 0.07% |
+4,109,589
| New | +$13.8M |
|
|
DCRC
306
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
| $15.6M | 0.07% |
+1,499,991
| New | +$15.6M |
|
307
Qiagen
QGEN
$8.53B
| $15.5M | 0.07% |
302,974
+141,612
| +88% | +$7.31M |
|
308
ZTO Express
ZTO
$18.2B
| $15.5M | 0.07% |
510,428
+477,361
| +1,444% | +$14.7M |
|
|
NGCA
309
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
| $15.4M | 0.07% |
+1,499,975
| New | +$15M |
|
310
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $15.4M | 0.07% |
+106,731
| New | +$14.9M |
|
311
Capital One
COF
$124B
| $15.4M | 0.07% |
99,292
-6,718
| -6% | -$1.01M |
|
312
PUT
Salesforce
CRM
$134B
| $15.3M | 0.07% |
62,700
+56,400
| +895% | +$13M |
|
313
Allegion
ALLE
$13B
| $15.3M | 0.07% |
109,923
+89,461
| +437% | +$12.2M |
|
314
PENN Entertainment
PENN
$2.74B
| $15.2M | 0.07% |
198,209
+110,310
| +125% | +$9.5M |
|
|
GRSV
315
DELISTED
Gores Holdings V, Inc.
GRSV
| $15.2M | 0.07% |
1,499,990
-70,458
| -4% | -$719K |
|
316
Intuitive Surgical
ISRG
$121B
| $15.1M | 0.07% |
49,116
+552
| +1% | +$155K |
|
317
Capri Holdings
CPRI
$1.77B
| $15M | 0.07% |
262,781
+126,709
| +93% | +$6.89M |
|
318
Skyworks Solutions
SWKS
$9.06B
| $14.9M | 0.07% |
77,657
+60,885
| +363% | +$10.8M |
|
|
KVSC
319
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $14.8M | 0.07% |
1,500,000
| – | – |
|
320
Align Technology
ALGN
$12B
| $14.8M | 0.07% |
24,200
-11,961
| -33% | -$7.08M |
|
321
Brown-Forman Class B
BF.B
$12B
| $14.8M | 0.07% |
196,932
-240,288
| -55% | -$18.3M |
|
322
Arthur J. Gallagher & Co
AJG
$63.7B
| $14.8M | 0.07% |
+105,330
| New | +$14.9M |
|
|
NEE.PRP
323
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $14.7M | 0.07% |
300,000
| – | – |
|
324
Enterprise Products Partners
EPD
$83.8B
| $14.7M | 0.07% |
608,521
+566,006
| +1,331% | +$13.4M |
|
325
American Electric Power
AEP
$73.7B
| $14.6M | 0.07% |
173,053
+158,228
| +1,067% | +$13.6M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.